Vault-13

CASI PHARMACEUTICALS INC CASIF

ORD SHS · Common Stock · CUSIP G1933S101

21 institutional holders -3 vs Q2 2024
1,322,5541.3m shares reported held*
8.5% of all shares outstanding*
$8.1mreported value*
2 new 4 added 2 reduced 5 sold out net bought ≈ $6.0m (+970.4k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 15.5m as of 2024-12-31, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $6.15. Options: 2 managers hold calls ($2.4k notional), 2 hold puts ($8.3k).

Trends to Q3 2024

Institutional holders

Managers reporting a position, each quarter

0102030Q4 22: 1Q1 23: 21Q2 23: 20Q3 23: 20Q4 23: 19Q1 24: 21Q2 24: 24Q3 24: 2121Q4 22Q2 23Q4 23Q2 24Q3 24
Numbers
QuarterHolders
Q4 20221
Q1 202321
Q2 202320
Q3 202320
Q4 202319
Q1 202421
Q2 202424
Q3 202421

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
20020Q1 23: 20 bought or addedQ1 23: 0 cut or sold outQ1 23Q2 23: 5 bought or addedQ2 23: 12 cut or sold outQ3 23: 5 bought or addedQ3 23: 9 cut or sold outQ3 23Q4 23: 6 bought or addedQ4 23: 9 cut or sold outQ1 24: 10 bought or addedQ1 24: 5 cut or sold outQ1 24Q2 24: 9 bought or addedQ2 24: 9 cut or sold outQ3 24: 6 bought or addedQ3 24: 7 cut or sold outQ3 24
Numbers
QuarterBought or addedCut or sold out
Q1 2023200
Q2 2023512
Q3 202359
Q4 202369
Q1 2024105
Q2 202499
Q3 202467

Calls vs puts

Options held, notional value, last 4 quarters. P/C = puts ÷ calls

CallsPuts
$0$5k$10k$15k$20kQ4 23 calls: $16.7kQ4 23 puts: $9.5kQ4 23P/C 0.57Q1 24 calls: $0Q1 24 puts: $0Q1 24P/C —Q2 24 calls: $1.0kQ2 24 puts: $0Q2 24P/C 0.00Q3 24 calls: $2.4kQ3 24 puts: $8.3kQ3 24P/C 3.50
Numbers
QuarterCallsPutsP/C
Q4 2023$16.7k$9.5k0.57
Q1 2024$0$0—
Q2 2024$1.0k$00.00
Q3 2024$2.4k$8.3k3.50

Biggest buyers

Venrock Adviser, LLC Added +875,573+875.6k
ADAR1 Capital Management, LLC Added +56,595+56.6k
Woodline Partners LP New +30,532+30.5k
CITADEL ADVISORS LLC New +22,714+22.7k
UBS Group AG Added +3,360+3.4k
RENAISSANCE TECHNOLOGIES LLC Added +700+700

Biggest sellers

HOWLAND CAPITAL MANAGEMENT LLC Sold out -15,072-15.1k
GEODE CAPITAL MANAGEMENT, LLC Reduced -2,858-2.9k
SIMPLEX TRADING, LLC Sold out -1,042-1.0k
Qube Research & Technologies Ltd Sold out -100-100
BANK OF AMERICA CORP /DE/ Reduced -25-25
Kozak & Associates, Inc. Sold out -10-10
Catalyst Funds Management Pty Ltd Sold out -8-8

Biggest calls

CITADEL ADVISORS LLC New $2.4k400 shares
CONCOURSE FINANCIAL GROUP SECURITIES, INC. Unchanged $00 shares

Biggest puts

CITADEL ADVISORS LLC New $8.3k1.4k shares
CONCOURSE FINANCIAL GROUP SECURITIES, INC. Unchanged $00 shares

Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

HolderStakeChangeShares Last filed
He Wei-Wu 13D · may seek influence +5.8 pts · filed 2026-05-18
Stated purposeOn April 17, 2026, ETP Global III Fund L.P. purchased a convertible note with the principal amount of US$5 million as the fourth tranche of the Issuer's US$20 million convertible note financing pursuant to certain convertible note purchase agreement (the "Purchase Agreement") between ETP Global III Fund L.P. and the Issuer dated December 11, 2025. A convertible note with a principal amount of US$5 million has been issued to the Purchaser on the same date (the "Convertible Note"). The Purchaser has the right to convert such note into the Company's ordinary shares, par value US$0.0001 per share (the "Ordinary Shares") at any time from and including the 91st day after the issuance thereof to and including the maturity date at a conversion price of the volume weighted average closing price of … Full filing
58.8% +5.8 pts 24.0m 2026-05-18
Panacea Innovation Ltd 13D · may seek influence +2.6 pts · filed 2025-12-17 22.5% +2.6 pts 4.7m 2025-12-17
Huang James 13G · passive investor filed 2025-07-23 13.8% 2.2m 2025-07-23
Chen Zhenfeng M 13G · passive new · filed 2025-11-26 11.0% new 2.3m 2025-11-26
Venrock Healthcare Capital Partners III, L.P. 13G · passive investor filed 2026-02-17 9.2% 2.0m 2026-02-17
SPARKLE BYTE LTD 13D · may seek influence filed 2026-01-20 5.0% 1.0m 2026-01-20

Fell to 5% or below in the last year: Foresite Capital Fund VI LP (0.0%, 2026-02-13), Ho Chi Sing (4.8%, 2026-01-20)

Insider purchases and sales in Q3 2024

Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.

None reported in Q3 2024.

Holders, Q3 2024

#ManagerLocationShares Value% of their portfolioChangeShares change
1 Venrock Adviser, LLC 0.32% of their portfolio NEW YORK, NY 987,259987.3k $6.1m $6.1m 0.32% Added +875.6k +875,573
2 Wellington Shields Capital Management, LLC 0.10% of their portfolio NEW YORK, NY 89,21789.2k $549.6k $549.6k 0.10% Unchanged
3 ADAR1 Capital Management, LLC 0.07% of their portfolio AUSTIN, TX 64,83564.8k $399.4k $399.4k 0.07% Added +56.6k +56,595
4 Wellington Shields & Co., LLC 0.08% of their portfolio NEW YORK, NY 43,09143.1k $265.4k $265.4k 0.08% Unchanged
5 RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio NEW YORK, NY 41,50041.5k $255.6k $255.6k 0.00% Added +700 +700
6 Woodline Partners LP 0.00% of their portfolio San Francisco, CA 30,53230.5k $188.1k $188.1k 0.00% New
7 CITADEL ADVISORS LLC 0.00% of their portfolio MIAMI, FL 22,71422.7k $135.4k $135.4k 0.00% New
8 GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio BOSTON, MA 19,36319.4k $115.4k $115.4k 0.00% Reduced -2.9k -2,858
9 UBS Group AG 0.00% of their portfolio ZURICH, V8 14,68114.7k $90.4k $90.4k 0.00% Added +3.4k +3,360
10 ROYAL BANK OF CANADA 0.00% of their portfolio TORONTO, A6 6,9006.9k $43.0k $43.0k 0.00% Unchanged
11 MORGAN STANLEY 0.00% of their portfolio NEW YORK, NY 1,4401.4k $8.9k $8.9k 0.00% Unchanged
12 WELLS FARGO & COMPANY/MN 0.00% of their portfolio SAN FRANCISCO, CA 506506 $3.1k $3.1k 0.00% Unchanged
13 BlackRock, Inc. 0.00% of their portfolio New York, NY 296296 $1.8k $1.8k 0.00% First filing
14 WEST PACES ADVISORS INC. 0.00% of their portfolio ATLANTA, GA 100100 $616 $616 0.00% Unchanged
15 JPMORGAN CHASE & CO 0.00% of their portfolio NEW YORK, NY 5050 $298 $298 0.00% Unchanged
16 BANK OF AMERICA CORP /DE/ 0.00% of their portfolio CHARLOTTE, NC 2828 $172 $172 0.00% Reduced -25 -25
17 NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 0.00% of their portfolio MILWAUKEE, WI 1313 $80 $80 0.00% Unchanged
18 Colonial Trust Co / SC 0.00% of their portfolio SPARTANBURG, SC 1111 $68 $68 0.00% Unchanged
19 TRUST CO OF VERMONT 0.00% of their portfolio BRATTLEBORO, VT 1010 $62 $62 0.00% Unchanged
20 OSAIC HOLDINGS, INC. 0.00% of their portfolio SCOTTSDALE, AZ 88 $49 $49 0.00% Unchanged
21 CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio BIRMINGHAM, AL 00 $0 $0 0.00% Unchanged